Global DNA Vaccines Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685580   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
DNA vaccines, also known as genetic vaccines or gene-based vaccines, are a novel approach to immunization that uses a small, circular piece of DNA containing genetic information from a pathogen, typically a virus or bacterium. When administered to a host, usually through injection, the DNA is taken up by host cells, which then use the genetic information to produce a harmless piece of the pathogen, such as a viral or bacterial protein. The immune system recognizes this foreign protein and mounts an immune response, including the production of antibodies and memory T-cells. DNA vaccines aim to prepare the immune system to recognize and defend against the actual pathogen if encountered in the future. DNA vaccines have shown potential in both human and veterinary medicine and are being researched for various infectious diseases and even some cancers. They offer advantages such as ease of production and potential for rapid response to emerging diseases.
According to DIResearch's in-depth investigation and research, the global DNA Vaccines market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of DNA Vaccines include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of DNA Vaccines. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global DNA Vaccines market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the DNA Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of DNA Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of DNA Vaccines Include:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
DNA Vaccines Product Segment Include:
Recombinant Protein Vaccine
Gene-Based Vaccine
DNA Vaccines Product Application Include:
Human
Animal
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global DNA Vaccines Industry PESTEL Analysis
Chapter 3: Global DNA Vaccines Industry Porter's Five Forces Analysis
Chapter 4: Global DNA Vaccines Major Regional Market Size and Forecast Analysis
Chapter 5: Global DNA Vaccines Market Size and Forecast by Type and Application Analysis
Chapter 6: North America DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global DNA Vaccines Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 DNA Vaccines Market Overview

1.1 Product Definition and Statistical Scope

1.2 DNA Vaccines Product by Type

1.2.1 Global DNA Vaccines Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Recombinant Protein Vaccine

1.2.3 Gene-Based Vaccine

1.3 DNA Vaccines Product by Application

1.3.1 Global DNA Vaccines Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Human

1.3.3 Animal

1.4 Global DNA Vaccines Market Revenue Analysis (2019-2030)

1.5 DNA Vaccines Market Development Status and Trends

1.5.1 DNA Vaccines Industry Development Status Analysis

1.5.2 DNA Vaccines Industry Development Trends Analysis

2 DNA Vaccines Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 DNA Vaccines Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global DNA Vaccines Market Analysis by Regions

4.1 DNA Vaccines Overall Market: 2023 VS 2024 VS 2030

4.2 Global DNA Vaccines Revenue and Forecast Analysis (2019-2030)

4.2.1 Global DNA Vaccines Revenue and Market Share by Region (2019-2024)

4.2.2 Global DNA Vaccines Revenue Forecast by Region (2025-2030)

5 Global DNA Vaccines Market Size by Type and Application

5.1 Global DNA Vaccines Market Size by Type

5.2 Global DNA Vaccines Market Size by Application

6 North America

6.1 North America DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America DNA Vaccines Market Size by Type

6.4 North America DNA Vaccines Market Size by Application

6.5 North America DNA Vaccines Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe DNA Vaccines Market Size by Type

7.4 Europe DNA Vaccines Market Size by Application

7.5 Europe DNA Vaccines Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China DNA Vaccines Market Size by Type

8.4 China DNA Vaccines Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) DNA Vaccines Market Size by Type

9.4 APAC (excl. China) DNA Vaccines Market Size by Application

9.5 APAC (excl. China) DNA Vaccines Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America DNA Vaccines Market Size by Type

10.4 Latin America DNA Vaccines Market Size by Application

10.5 Latin America DNA Vaccines Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa DNA Vaccines Market Size by Type

11.4 Middle East & Africa DNA Vaccines Market Size by Application

11.5 Middle East & Africa DNA Vaccines Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global DNA Vaccines Market Revenue by Key Manufacturers (2020-2024)

12.2 DNA Vaccines Competitive Landscape Analysis and Market Dynamic

12.2.1 DNA Vaccines Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Merck

13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Merck DNA Vaccines Product Portfolio

13.1.3 Merck DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 GSK

13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 GSK DNA Vaccines Product Portfolio

13.2.3 GSK DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Sanofi

13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Sanofi DNA Vaccines Product Portfolio

13.3.3 Sanofi DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Zoties

13.4.1 Zoties Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Zoties DNA Vaccines Product Portfolio

13.4.3 Zoties DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Elanco

13.5.1 Elanco Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Elanco DNA Vaccines Product Portfolio

13.5.3 Elanco DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Boehringer-Ingelheim

13.6.1 Boehringer-Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Boehringer-Ingelheim DNA Vaccines Product Portfolio

13.6.3 Boehringer-Ingelheim DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Indian Immunologicals

13.7.1 Indian Immunologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Indian Immunologicals DNA Vaccines Product Portfolio

13.7.3 Indian Immunologicals DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Plumbline Life Sciences

13.8.1 Plumbline Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Plumbline Life Sciences DNA Vaccines Product Portfolio

13.8.3 Plumbline Life Sciences DNA Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 DNA Vaccines Industry Chain Analysis

14.2 DNA Vaccines Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 DNA Vaccines Typical Downstream Customers

14.4 DNA Vaccines Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support